Cargando…
Aberrant phenotypes of transgenic mice expressing dimeric human erythropoietin
BACKGROUND: Dimeric human erythropoietin (dHuEPO) peptides are reported to exhibit significantly higher biological activity than the monomeric form of recombinant EPO. The objective of this study was to produce transgenic (tg) mice expressing dHuEPO and to investigate the characteristics of these mi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284390/ https://www.ncbi.nlm.nih.gov/pubmed/22284751 http://dx.doi.org/10.1186/1477-7827-10-6 |
_version_ | 1782224358512525312 |
---|---|
author | Yun, Seong-Jo Naidansuren, Purevjargal Sim, Bo-Woong Park, Jong-Ju Park, Cha-Won Nanjidsuren, Tseeleema Kang, Myung-Hwa Hwang, Sue-Yun Yoon, Jong-Taek Min, Kwan-Sik |
author_facet | Yun, Seong-Jo Naidansuren, Purevjargal Sim, Bo-Woong Park, Jong-Ju Park, Cha-Won Nanjidsuren, Tseeleema Kang, Myung-Hwa Hwang, Sue-Yun Yoon, Jong-Taek Min, Kwan-Sik |
author_sort | Yun, Seong-Jo |
collection | PubMed |
description | BACKGROUND: Dimeric human erythropoietin (dHuEPO) peptides are reported to exhibit significantly higher biological activity than the monomeric form of recombinant EPO. The objective of this study was to produce transgenic (tg) mice expressing dHuEPO and to investigate the characteristics of these mice. METHODS: A dHuEPO-expressing vector under the control of the goat beta-casein promoter, which produced a dimer of human EPO molecules linked by a 2-amino acid peptide linker (Asp-Ile), was constructed and injected into 1-cell fertilized embryos by microinjection. Mice were screened using genomic DNA samples obtained from tail biopsies. Blood samples were obtained by heart puncture using heparinized tubes, and hematologic parameters were assessed. Using the microarray analysis tool, we analyzed differences in gene expression in the spleens of tg and control mice. RESULTS: A high rate of spontaneous abortion or death of the offspring was observed in the recipients of dHuEPO embryos. We obtained 3 founder lines (#4, #11, and #47) of tg mice expressing the dHuEPO gene. However, only one founder line showed stable germline integration and transmission, subsequently establishing the only transgenic line (#11). We obtained 2 F1 mice and 3 F2 mice from line #11. The dHuEPO protein could not be obtained because of repeated spontaneous abortions in the tg mice. Tg mice exhibited symptoms such as short lifespan and abnormal blood composition. The red blood cell count, white blood cell count, and hematocrit levels in the tg mice were remarkably higher than those in the control mice. The spleens of the tg mice (F1 and F2 females) were 11- and -21-fold larger than those of the control mice. Microarray analysis revealed 2,672 spleen-derived candidate genes; more genes were downregulated than upregulated (849/764). Reverse transcriptase-polymerase chain reaction (RT-PCR) and quantitative real-time PCR (qRT-PCR) were used for validating the results of the microarray analysis of mRNA expression. CONCLUSIONS: In conclusion, dHuEPO tg mice caused excessive erythrocytosis that led to abnormal blood composition, short lifespan, and abnormal splenomegaly. Further, we identified 2,672 genes associated with splenomegaly by microarray analysis. These results could be useful in the development of dHuEPO-producing tg animals. |
format | Online Article Text |
id | pubmed-3284390 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-32843902012-02-25 Aberrant phenotypes of transgenic mice expressing dimeric human erythropoietin Yun, Seong-Jo Naidansuren, Purevjargal Sim, Bo-Woong Park, Jong-Ju Park, Cha-Won Nanjidsuren, Tseeleema Kang, Myung-Hwa Hwang, Sue-Yun Yoon, Jong-Taek Min, Kwan-Sik Reprod Biol Endocrinol Research BACKGROUND: Dimeric human erythropoietin (dHuEPO) peptides are reported to exhibit significantly higher biological activity than the monomeric form of recombinant EPO. The objective of this study was to produce transgenic (tg) mice expressing dHuEPO and to investigate the characteristics of these mice. METHODS: A dHuEPO-expressing vector under the control of the goat beta-casein promoter, which produced a dimer of human EPO molecules linked by a 2-amino acid peptide linker (Asp-Ile), was constructed and injected into 1-cell fertilized embryos by microinjection. Mice were screened using genomic DNA samples obtained from tail biopsies. Blood samples were obtained by heart puncture using heparinized tubes, and hematologic parameters were assessed. Using the microarray analysis tool, we analyzed differences in gene expression in the spleens of tg and control mice. RESULTS: A high rate of spontaneous abortion or death of the offspring was observed in the recipients of dHuEPO embryos. We obtained 3 founder lines (#4, #11, and #47) of tg mice expressing the dHuEPO gene. However, only one founder line showed stable germline integration and transmission, subsequently establishing the only transgenic line (#11). We obtained 2 F1 mice and 3 F2 mice from line #11. The dHuEPO protein could not be obtained because of repeated spontaneous abortions in the tg mice. Tg mice exhibited symptoms such as short lifespan and abnormal blood composition. The red blood cell count, white blood cell count, and hematocrit levels in the tg mice were remarkably higher than those in the control mice. The spleens of the tg mice (F1 and F2 females) were 11- and -21-fold larger than those of the control mice. Microarray analysis revealed 2,672 spleen-derived candidate genes; more genes were downregulated than upregulated (849/764). Reverse transcriptase-polymerase chain reaction (RT-PCR) and quantitative real-time PCR (qRT-PCR) were used for validating the results of the microarray analysis of mRNA expression. CONCLUSIONS: In conclusion, dHuEPO tg mice caused excessive erythrocytosis that led to abnormal blood composition, short lifespan, and abnormal splenomegaly. Further, we identified 2,672 genes associated with splenomegaly by microarray analysis. These results could be useful in the development of dHuEPO-producing tg animals. BioMed Central 2012-01-27 /pmc/articles/PMC3284390/ /pubmed/22284751 http://dx.doi.org/10.1186/1477-7827-10-6 Text en Copyright ©2012 Yun et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Yun, Seong-Jo Naidansuren, Purevjargal Sim, Bo-Woong Park, Jong-Ju Park, Cha-Won Nanjidsuren, Tseeleema Kang, Myung-Hwa Hwang, Sue-Yun Yoon, Jong-Taek Min, Kwan-Sik Aberrant phenotypes of transgenic mice expressing dimeric human erythropoietin |
title | Aberrant phenotypes of transgenic mice expressing dimeric human erythropoietin |
title_full | Aberrant phenotypes of transgenic mice expressing dimeric human erythropoietin |
title_fullStr | Aberrant phenotypes of transgenic mice expressing dimeric human erythropoietin |
title_full_unstemmed | Aberrant phenotypes of transgenic mice expressing dimeric human erythropoietin |
title_short | Aberrant phenotypes of transgenic mice expressing dimeric human erythropoietin |
title_sort | aberrant phenotypes of transgenic mice expressing dimeric human erythropoietin |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284390/ https://www.ncbi.nlm.nih.gov/pubmed/22284751 http://dx.doi.org/10.1186/1477-7827-10-6 |
work_keys_str_mv | AT yunseongjo aberrantphenotypesoftransgenicmiceexpressingdimerichumanerythropoietin AT naidansurenpurevjargal aberrantphenotypesoftransgenicmiceexpressingdimerichumanerythropoietin AT simbowoong aberrantphenotypesoftransgenicmiceexpressingdimerichumanerythropoietin AT parkjongju aberrantphenotypesoftransgenicmiceexpressingdimerichumanerythropoietin AT parkchawon aberrantphenotypesoftransgenicmiceexpressingdimerichumanerythropoietin AT nanjidsurentseeleema aberrantphenotypesoftransgenicmiceexpressingdimerichumanerythropoietin AT kangmyunghwa aberrantphenotypesoftransgenicmiceexpressingdimerichumanerythropoietin AT hwangsueyun aberrantphenotypesoftransgenicmiceexpressingdimerichumanerythropoietin AT yoonjongtaek aberrantphenotypesoftransgenicmiceexpressingdimerichumanerythropoietin AT minkwansik aberrantphenotypesoftransgenicmiceexpressingdimerichumanerythropoietin |